The use of tranexamic acid to reduce blood loss during total knee arthroplasty.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 14629944.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The fall in haemoglobin following unilateral total knee arthroplasty is reduced by tranexamic acid administration. 60 patients were studied in total, 30 received tranexamic acid 10 mg/kg on induction and a further dose shortly before the release of the tourniquet. Surgery was performed by the senior author in a standardised fashion using the Freeman Samuelson cemented total knee replacement. Haemoglobin levels were measured 2 weeks pre and 3 days post operatively. Any complications were noted. A control group was matched using the Bone and Joint Research Unit database for age, sex, disease and pre-operative haemoglobin level. This group had been monitored in the same way as the group treated with tranexamic acid. In the group receiving no tranexamic acid the mean fall in haemoglobin was 2.8 g/dl (95% CI of mean 2.5-3.2) and in the group treated with tranexamic acid 1.7 g/dl (95% CI of mean 1.3-2) P<0.01. There were no complications in either group. The administration of tranexamic acid is an effective method of reducing the haemoglobin fall following knee arthroplasty.
Medical subject headings
- Antifibrinolytic Agents
- Arthroplasty, Replacement, Knee
- Blood Loss, Surgical
- Tranexamic Acid
Anatomy
- knee